FMP
Parx Materials N.V.
MLPRX.PA
EURONEXT
Inactive Equity
Parx Materials N.V. engages in the manufacture and sale of antibacterial/antimicrobial plastics worldwide. The company offers its products for food contact applications and food packaging; medical devices and implants; textiles; pipes and drainages; and anti-fouling and hygiene applications, as well as to prevent mold and material deterioration; and biofilm formation. It holds a patented technology under the Saniconcentrate name. The company was formerly known as Parx Plastics N.V. and changed its name to Parx Materials N.V. in January 2020. Parx Materials N.V. was incorporated in 2012 and is headquartered in Rotterdam, the Netherlands.
0.29 EUR
-0.03 (-10.34%)
DuPont Analysis
The DuPont analysis, pioneered by the DuPont Corporation, offers a structured approach to assessing fundamental performance. It involves breaking down the return on equity (ROE) into various components, aiding investors in comprehending the factors influencing a company's returns.
ROE = Net Income / Average Total Equity
ROE = (Net Income / Sales) * (Revenue / Average Total Assets) * (Average Total Assets / Average Total Equity)
The company's tax burden is (Net income ÷ Pretax profit). This is the proportion of the company's profits retained after paying income taxes. [NI/EBT] The company's interest burden is (Pretax income ÷ EBIT). This will be 1.00 for a firm with no debt or financial leverage. [EBT/EBIT] The company's operating income margin or return on sales (ROS) is (EBIT ÷ Revenue). This is the operating income per dollar of sales. [EBIT/Revenue] The company's asset turnover (ATO) is (Revenue ÷ Average Total Assets). The company's equity multiplier is (Average Total Assets ÷ Average Total Equity). This is a measure of financial leverage. Profitability (measured by profit margin) Asset efficiency (measured by asset turnover) Financial leverage (measured by equity multiplier)
